Evidence map›Paper›PMID 16734558›Full record

ArticleJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research2006

Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.

Ruijiang Song, Shuqin Liu, Robert J Adams, Kam W Leong

Abstract readComparative Study
In one paragraph

Article in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Development of Peptide Vaccines in Dengue.Current pharmaceutical design · 2018
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Effects of MIP-1α, MIP-3α, and MIP-3β on the Induction of HIV Gag-specific Immune Response with DNA Vaccines.Molecular therapy : the journal of the American Society of Gene Therapy · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ruijiang SongDepartment of Pharmacology and Molecular Sciences, the Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Shuqin Liu
Robert J Adams
Kam W Leong
Johns Hopkins University · US

Funding

CYTOKINE DELIVERY SYSTEMS IN CANCER VACCINE DESIGNR01CA068011 · NCI · JOHNS HOPKINS UNIVERSITY · PI LEONG, KAM W · 1996 to 1998
–
PARTICULATE HIV VACCINE DESIGNR21AI042718 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LEONG, KAM W · 1997 to 1998
–
NCI NIH HHS CA68011NCI NIH HHS R01 CA068011NIAID NIH HHS AI42718
6 · The paper itself

Abstract

Controlled release of granulocyte-macrophage colony-stimulating factor (GM-CSF) protein by albumin-heparin microparticles administered via intramuscular vaccination in conjunction with HIV DNA vaccines stimulated HIV Gag-specific immune responses. In the murine model, Gag-specific cytotoxic T lymphocyte (CTL) and T helper (Th) responses were significantly enhanced by administration of murine GM-CSF microparticles. This effect was comparable to a GM-CSF encoded plasmid. In three of four rhesus monkeys, enhancement of Gag-specific antibody (Ab), Th, and CTL responses was observed 1 month after the first immunization with coadministration of human GM-CSF microparticles and HIV Gag plasmid. The second, third, and fourth booster immunizations, however, did not increase the Gag-specific immune responses. Subsequent application of Gag protein in complete Freund's adjuvant (CFA) significantly enhanced Ab and Th, but not CTL. However, Gag-specific CTL response was triggered by cytokine and Gag p55-encapsulated microparticles in all animals. The strategy of priming immune responses by coadministration of cytokine microparticles and DNA vaccines, followed by boosting with cytokine and antigen protein-encapsulated microparticles, may prove effective in improving an HIV DNA vaccine design.

Indexed as

HIVAlbuminsAnimalsCytotoxicity Tests, ImmunologicFemaleGene Products, gagGranulocyte-Macrophage Colony-Stimulating FactorHeparinHumansInjections, IntramuscularMacaca mulattaMiceMice, Inbred BALB CMicrospheresModels, AnimalMuscle, SkeletalAlbuminsGene Products, gagGranulocyte-Macrophage Colony-Stimulating FactorHeparinRecombinant ProteinsVaccines, DNA

Identifiers

PMID16734558
PMCPMC2376816
OpenAlexW2001118017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.